Literature DB >> 16638098

Abnormal gastroesophageal flap valve is highly associated with gastroesophageal reflux disease among subjects undergoing routine endoscopy in Taiwan.

Bor-Ru Lin1, Jau-Min Wong, Mei-Chi Chang, Chien-Chung Liao, Pei-Ming Yang, Jiiang-Huei Jeng, Wan-Ru Liao, Teh-Hong Wang.   

Abstract

OBJECTIVE: Gastroesophageal flap valve (GEFV) grade predicts severe gastroesophageal reflux disease in Caucasians, but its role in other populations is unclear. This study evaluated the significance of endoscopic grading of the GEFV in Taiwanese subjects.
METHODS: Five hundred and six consecutive patients undergoing routine check-ups at the National Taiwan University Hospital were enrolled. Symptoms of upper gastrointestinal disease and endoscopic severity of esophageal mucosal injury were correlated to GEFV grades according to the Hill classification.
RESULTS: The frequency of abnormal valves (Hill grades III or IV) was 27.3%. Of these, 42.7% had erosive esophagitis (EE). The majority of patients with EE were classified as Los Angeles grades A and B (79.7 and 16.9%, respectively). The prevalence of EE, hiatal hernia and, to a lesser degree, non-erosive reflux disease, increased with altered GEFV. Patients with abnormal valves were younger and more likely to be male, overweight, and to have atypical and extraesophageal symptoms.
CONCLUSIONS: Taiwanese patients with abnormal GEFVs share similar characteristics and risk factors with the patients who have EE. Endoscopic grading of the GEFV is highly associated with GERD, and in particular EE, in subjects undergoing routine endoscopy.

Entities:  

Mesh:

Year:  2006        PMID: 16638098     DOI: 10.1111/j.1440-1746.2005.04003.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Correlation of the gastroesophageal flap valve grade with the surgery rate in patients with gastroesophageal reflux disease.

Authors:  Huseyin Ayhan Kayaoglu
Journal:  Surg Endosc       Date:  2012-10-06       Impact factor: 4.584

2.  The effect of gastroesophageal flap valve appearance on the management of patients with symptoms of gastroesophageal reflux disease.

Authors:  Elias Xirouchakis; Dimitrios Kamberoglou; Dimitrios Kalos; Evanthia Zambeli; Vassilios Doulgeroglou; Vassilios Tzias
Journal:  Dig Dis Sci       Date:  2008-07-04       Impact factor: 3.199

3.  Endoscopic grading of the gastroesophageal flap valve is correlated with reflux activity and can predict the size of the esophageal hiatus in patients with gastroesophageal reflux disease.

Authors:  Oliver Owen Koch; Georg Spaun; Stavros A Antoniou; Charlotte Rabl; Gernot Köhler; Klaus Emmanuel; Dietmar Öfner; Rudolph Pointner
Journal:  Surg Endosc       Date:  2013-07-12       Impact factor: 4.584

4.  Impacts of endoscopic gastroesophageal flap valve grading on pediatric gastroesophageal reflux disease.

Authors:  Kai-Chi Chang; Jia-Feng Wu; Wei-Chung Hsu; Bor-Ru Lin; Huey-Ling Chen; Yen-Hsuan Ni
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

5.  Endoscopic findings around the gastroesophageal junction: an experience from a tertiary hospital in Korea.

Authors:  Ji Hyun Kim; Jin Ki Hwang; Juhyung Kim; Sehe Dong Lee; Beom Jae Lee; Jae Seon Kim; Young-Tae Bak
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

6.  Abnormal Gastroesophageal Flap Valve Is Associated With High Gastresophageal Reflux Disease Questionnaire Score and the Severity of Gastroesophageal Reflux Disease in Vietnamese Patients With Upper Gastrointestinal Symptoms.

Authors:  Duc T Quach; Trang T Nguyen; Toru Hiyama
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

7.  Preoperative diagnosis of hiatal hernia: barium swallow X-ray, high-resolution manometry, or endoscopy?

Authors:  Michael Weitzendorfer; Gernot Köhler; Stavros A Antoniou; Leo Pallwein-Prettner; Lisa Manzenreiter; Philipp Schredl; Klaus Emmanuel; Oliver Owen Koch
Journal:  Eur Surg       Date:  2017-09-19       Impact factor: 0.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.